Immunogenicity and Safety of Influenza and COVID-19 Multicomponent Vaccine in Adults â‰¥50 Years: A Randomized Clinical Trial
COVID-19 mRNA Vaccination and 4-Year All-Cause Mortality Among Adults Aged 18 to 59 Years in France
